End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.81 CNY | +2.60% | -0.65% | -7.93% |
May. 13 | NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US | MT |
May. 01 | NKFPharma Gets Nod to Register New Cancer Treatment | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Neutral |
Resistance | 13.95 | 16.24 | 15.90 |
Spread/Res. | -1.00% | -14.96% | -13.14% |
Spread/Supp. | +5.66% | +24.75% | +23.19% |
Support | 13.07 | 11.07 | 11.21 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 603707 Stock
- Charts Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.